Products & Reviews

Plasma-SeqSensei™ (PSS) CRC RUO Kit allows the highly sensitive and specific detection of mutations in circulating tumour DNA (ctDNA) from plasma of patients with colorectal cancer (CRC). The kit is based on the next-generation sequencing technology and covers key mutations of the MAPK signaling genes KRAS, NRAS and BRAF and the PIK3CA genes. These genes significantly contribute to the development of colorectal cancer and a…

The Plasma-SeqSensei™ (PSS) Melanoma RUO (research use only) Kit allows the highly sensitive and specific detection of mutations in circulating tumour DNA (ctDNA) from plasma of patients with melanoma cancer. The kit is based on the next-generation sequencing technology and covers key mutations of the BRAF and NRAS oncogenes. These genes have been shown to enhance tumour growth, promote disease progression and can be consid…

The Plasma-SeqSensei™ (PSS) NSCLC RUO (research use only) Kit detects mutations in circulating tumour DNA (ctDNA) from plasma in patients with non-small cell lung cancer. The kit uses next generation sequencing for the detection and identification of mutations in BRAF, EGFR, KRAS, and PIK3CA genes in human cfDNA isolated from blood plasma which play a significant role in the development of NSCLC and are relevant biomarkers…

Power in a new dimension

Count. Smear. Stain. All-in-one haematology

The Plasma-SeqSensei™ (PSS) Thyroid Cancer RUO (research use only) Kit detects mutations in circulating tumour DNA (ctDNA) from plasma in patients with thyroid cancer.

Challenges are welcome. When you are confident.

Clinical flow cytometer for immunophenotyping

Antimicrobial susceptibility testing for near-patient settings

XR-Series has evolved from XN-Series – it draws on XN’s legacy by incorporating the many strong points that customers have come to appreciate and rely on in labs across the globe. Sysmex have added new useful assets and refined the approach of ‘tailoring your haematology’ even further to achieve a perfect fit for more laboratories than ever.